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Animals lacking the inducible nitric oxide synthase gene (nos2−/−) are less susceptible to
Mycobacterium avium strain 25291 and lack nitric oxide-mediated immunomodulation of
CD4+ T cells. Here we show that the absence of nos2 results in increased accumulation
of neutrophils and both CD4+ and CD8+ T cells within the M. avium containing granu-
loma. Examination of the T-cell phenotype in M. avium infected mice demonstrated that
CD4+CD44hi effector T cells expressing the Th1 transcriptional regulator T-bet (T-bet+)
were specifically reduced by the presence of nitric oxide. Importantly, the T-bet+ effector
population could be separated into CD69hi and CD69lo populations, with the CD69lo popu-
lation only able to accumulate during chronic infectionwithin infected nos2−/− mice. Tran-
scriptomic comparison between CD4+CD44hiCD69hi and CD4+CD44hiCD69lo populations
revealed that CD4+CD44hiCD69lo cells had higher expression of the integrin itgb1/itga4
(VLA-4, CD49d/CD29). Inhibition of Nos2 activity allowed increased accumulation of the
CD4+CD44hiT-bet+CD69lo population in WT mice as well as increased expression of
VLA-4. These data support the hypothesis that effector T cells in mycobacterial granulo-
mata are not a uniform effector population but exist in distinct subsets with differential
susceptibility to the regulatory effects of nitric oxide.
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Introduction
Infection with Mycobacterium species can result in chronic dis-
ease and sustained stimulation of the immune response that
needs to be regulated in order to control bacterial growth with-
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out destroying host tissue [1]. Nitric oxide has a wide variety of
regulatory activities, which can affect the chronic host response
to infection [2–5]. In the case of Mycobacterium avium, the bac-
teria are not susceptible to the toxic effects of nitric oxide [6],
allowing us to probe the role of reactive nitrogen intermediates
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in regulation of the T-cell response to mycobacterial infec-
tion without the confounding factor of uncontrolled bacterial
growth.
Nitric oxide acts on physiological systems with effects depen-
dent upon concentration, the relative levels of reactive oxygen
radicals and pH [7]. At low concentrations, nitric oxide acts as a
signaling molecule, either in a cGMP-dependent or -independent
manner, to promote vascular integrity, mediate neurotransmis-
sion, and regulate cellular respiration by altering the affinity of
cytochrome C for oxygen [7, 8]. At high concentrations, nitric
oxide inhibits respiration and causes nitrosative damage to pro-
teins, lipid peroxidation, and DNA [9, 10]. The balance between
nitric oxide and oxygen radicals is important, as nitric oxide
can reduce oxidative stress [11] but also generates peroxynitrite,
which is itself damaging [12]. The damage generated by high
levels of nitric oxide is detrimental to cells and results in
apoptosis [9].
The impact of nitric oxide on the immune response has been
extensively analyzed with identification of both positive and
negative regulatory roles [13]. In humans, nitric oxide limits
IL-2 release and proliferation of T cells via activation of the
cGMP-dependent protein kinase, cGK I [14]. In Trypanosoma
brucei mouse models, nitric oxide inhibits the accumulation of
IL-2- and IFN-γ-producing T cells [15]. In both an in vitro sys-
tem [16] and a Listeria monocytogenes mouse model [17], the
inhibition of nitric oxide synthase (Nos) results in improved
antigen-specific T-cell responses. Nitric oxide also acts as an
anti-inflammatory agent by limiting the interaction of leuco-
cytes with the endothelial monolayer [18]. Nitric oxide can
drive IL-10-producing regulatory T cells, limit the expansion of
Th17 cells [19, 20], and regulate the IL-12 pathway both pos-
itively [21] and negatively [22]. Indeed, at low levels, it can
augment the generation of Th1 cells by increasing expression
of IL-12Rβ2 [23, 24] and augment IFN-γ−mediated signaling
[25].
In mycobacterial disease, nitric oxide is essential for the con-
trol of Mycobacterium tuberculosis but dispensable for the control
of M. avium [4]. It limits the accumulation of activated T cells
in the Mycobacterium bovis BCG model [26], the M. tuberculo-
sis model [27], and the M. avium model [6] with an increased
IFN-γ response being seen in both M. avium [6] and M. tuber-
culosis infected nos2−/− mice [28]. Absence of nitric oxide in
M. avium infection results in lesions with increased cellularity and
collagen deposition [6, 29, 30]. Thus, nitric oxide acts to limit
T-cell responses and immunopathology during mycobacterial
infection and in the absence of nitric oxide, there is improved
IFN-γ production [6].
The impact of nitric oxide on specific subsets of activated
T cells has not been extensively studied; however, recent
data shows that while some antigen-specific CD4+ T-cell effec-
tors are able to persist within the mycobacterially induced
inflammatory environment, other effector cells are not [31].
Specifically, T cells that can produce IFN-γ but which main-
tain the capacity to proliferate are better able to persist in
mycobacterially infected mice than are T cells with higher
IFN-γ production but lower proliferative capacity [31]. As nitric
oxide is known to be involved in both initiation and regula-
tion of the IFN-γ-producing CD4+ T-cell population, we inves-
tigated whether different subsets of effector CD4+ T cells were
differentially susceptible to nitric oxide during mycobacterial dis-
ease.
Results
The bacterial burden and the granuloma in WT
and nos2−/− mice differ
We examined bacterial burden and granuloma formation fol-
lowing a moderate intravenous dose of M. avium 25291. Fig-
ure 1A demonstrates that growth of M. avium 25291 was
reduced in nos2−/− mice compared with that in wild-type (WT)
mice and that cellular inflammation was different between
the two groups [30, 32]. There was a preponderance of
mononuclear phagocytes with large cytoplasm in the WT mice
(Fig. 1B) while the lesions in the nos2−/− mice were more cir-
cumscribed with macrophages and lymphocytes forming a man-
tle around a central area of neutrophil-like cells (Fig. 1C).
These data confirm that the WT and nos2−/− mice differ in
response toM. avium 25291 with impaired bacterial control in WT
mice and more complex granuloma development in the nos2−/−
mice.
Absence of Nos2 promotes lymphocytes and granulo-
cytes accumulation in the M. avium induced lesion
To better define the cells within the WT and nos2−/− lesions, we
probed live sections of infected liver tissue with antibody spe-
cific for macrophage (F4/80), neutrophil (Ly6G), and lymphocyte
(CD4 and CD8) markers.
We found greater numbers of CD4+ or CD8+ cells through-
out the F4/80+ macrophage defined lesion in the nos2−/− mouse
(Fig. 2B) compared with the WT mouse (Fig. 2A). Further, there
were significantly more Ly6G+ cells within the nos2−/− lesions
(Fig. 2D) compared to theWT lesions (Fig. 2C) and these appeared
to coalesce in central areas (Fig. 2D). These data show that both
lymphocytes and neutrophils accumulate more readily within the
macrophage-defined lesions of M. avium infected nos2−/− com-
pared to WT mice.
As lymphocytes were absent from the WT lesions, we wanted
to compare the environment created within the F4/80 dom-
inated lesions of the WT and nos2−/− mice. To do this, we
stained cryosections from infected WT and nos2−/− livers for
the enzymes required to generate toxic oxygen and nitrogen
radicals. We found that p22-phox, a critical subunit of the
NADPH oxidase required for oxygen radical generation [33], was
readily expressed throughout the phagocyte areas of both WT
(Fig. 2E) and nos2−/− mice (Fig. 2F). The Nos2 protein
was less widely expressed in the WT lesions (Fig. 2G)
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Figure 1. Bacterial burden and inflammation differ in Mycobacterium
avium infected WT and nos2−/− mice. (A) WT (black bars) and nos2−/−
(white bars) mice were infected intravenously with 106 M. avium 25291,
livers were harvested on the indicated days and the number of colony
forming units determined. Data are shown as mean + SEM of n = 5
and are representative of three independent experiments. ***p < 0.001,
Student’s t-test. (B, C) Livers from infected (B) WT and (C) nos2−/− mice
were also processed for histological analysis on day 120 using hema-
toxylin and eosin (original magnification 200×). Arrows in (C) show
margin of granuloma and central area of granulocytic cells not present
in (B). Data shown are representative of five animals per group and two
similar experiments.
Figure 2. The absence of Nos2 promotes accumulation of lymphocytes
and granulocytes in the Mycobacterium avium induced lesion. WT (A, C,
E, G) and nos2−/− (B, D, F, H) mice were infected intravenously with 106
M. avium 25291 and the livers harvested on day 120. (A–D) Livers were
placed directly in agar and rapidly sectioned without fixation using a
vibratingmicrotome. Tissue sliceswere stainedwith the F4/80 antibody
(blue in A–D) and anti-CD4/CD8 antibody (red in A and B) or anti-Ly6G
antibody (red in C and D, original magnification 200×). Data shown
are representative of six total animals over three experiments. (E–H)
Livers were also harvested for cryosectioning and frozen sections were
stained for CD4 (red) CD8 (blue) and either p22-phox (green, E, F) or
Nos2 (green G, H, original magnification 200×). Nuclear stain is white.
Data shown are representative of four animals per group, and of two
experiments performed.
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and was absent in the nos2−/− lesions (Fig. 2H). Both
CD4+ (red) and CD8+ (blue) cells were seen in the p22-
phox positive WT tissues (Fig. 2E) but were much more
prevalent in the p22-phox area in the nos2−/− tissues
(Fig. 2F). The CD4+ T cells were significantly increased
in the sections from nos2−/− livers with an average of
321±100 CD4+ cells per section versus an average of 93±29
cells per section in the WT (p = 0.0046 by Student’s
t-test). These data demonstrate that while Nos2 is not as widely
expressed as p22-phox, it severely affects the ability of CD4+ and
CD8+ lymphocytes to accumulate within the mycobacterial gran-
uloma.
Activated effector lymphocytes within infected organs
are differentially affected by nitric oxide
Mycobacterium avium infected WT mice undergo a profound
IFN-γ-dependent depletion of lymphocytes; however, the impact
of Nos2 in this model is not to substantially deplete T cells but
to reduce the level of the IFN-γ response [6, 34]. Figure 2 sug-
gests that T cells are specifically excluded from the phagocytic
areas in M. avium infected WT mice in a nitric oxide-dependent
manner. To determine whether the histological results in the WT
lesions represented the depletion of all or a specific subset of lym-
phocytes from the affected organ, we compared the CD4+ T cells
within infected organs by flow cytometry. We found only a mod-
est effect of nos2 deficiency on the total frequency and number of
either live lymphocytes or CD4+ T cells in infected organs com-
pared to WT mice (Supporting Information Fig. 1). This trend was
seen before but had not reached statistical significance in previous
studies [6,34].
To determine whether the nos2 gene was adversely affecting
activated effector cells, we compared the frequency (Fig. 3A) and
number (Fig. 3B) of CD4+ T cells expressing the Th1-associated
transcription factor, T-bet. We found that the CD4+ T-bet+ popu-
lation was significantly and substantially increased in the nos2−/−
mice relative to the WT mice in all infected organs (Fig. 3). These
data demonstrate that the presence of nos2 limits the accumula-
tion of Th1-type T cells and that these activated effector cells were
either more susceptible to depletion or failed to develop in the
presence of Nos2.
To investigate whether all activated T-bet+ cells were equally
affected by the presence of nos2, we stained CD4+ T cells from
all infected organs for both T-bet and CD69, a molecule that is
upregulated upon antigen exposure [35]. The pattern of stain-
ing is shown in Fig. 4A. We found that in all three organs, the
frequency and number (Fig. 4B) of CD69hi T-bet+ CD4+ T cells
were only modestly affected by the absence of nos2. In contrast,
the CD69loT-bet+ CD4+ T-cell population failed to accumulate in
the WT mice but did accumulate in the spleen, liver, and lung of
the nos2−/− mice (Fig. 4C). These data demonstrate that the nos2
gene has the capacity to limit accumulation of CD69loT-bet+ CD4+
T cells.
CD4+CD44hiCD69hi and CD4+CD44hiCD69lo cells have
distinct transcriptomes in vivo
To define the basis of the increased susceptibility to nos2 of the
CD69loT-bet+ cells relative to the CD69hiT-bet+ cells, we com-
pared gene transcription immediately ex vivo in CD4+ T cells
sorted based on CD44 and CD69 expression using an unbi-
ased microarray approach. Equivalent numbers of cells differ-
ing only in the expression of CD69 (CD4+CD44hiCD69hi versus
CD4+CD44hiCD69lo), were purified using fluorescence-activated
cell sorting from the splenocytes of WT and nos2−/− mice infected
with M. avium 80 days previously (all CD44hi cells are T-bet+ in
this model, data not shown). Global RNA expression was analyzed
for differential gene expression and class comparison (Fig. 5). We
found that there was differential expression between the four pop-
ulations of cells of 911 sequences detected by unique probes and
that the patterns for individual mice within each groupwere repro-
ducible (Fig. 5A). Importantly, we found that gene expression
patterns were associated with both genotype of the mouse (WT
versus nos2−/−) and phenotype of the cells (CD69hi versus CD69lo)
and that there were differences between the gene expression
patterns for the CD4+CD44hiCD69lo cells isolated from WT and
nos2−/− mice (black arrows in Fig. 5A). The log intensity values
of the microarray data set are available in Supporting Information
Table 1.
To probe the data sets for biological relevance, we com-
pared the differential gene expression data against 218 pre-
defined gene lists representing previously investigated mouse
biological processes. Two pathways were identified as being
significantly represented in the differentially expressed data
set and both contained the genes for the heterodimeric inte-
grin known as very late antigen-4 (VLA-4, CD49d/CD29)
(Fig. 5B).
By further comparing specific gene expression within the indi-
vidual samples (n = 3), we were able to define statistically dif-
ferent gene expression for genes of interest. We found that the
CD4+CD44hiCD69lo population from both the WT and nos2−/−
infected mice expressed less il2, il2ra, il2rb, and ifngr2 than
did the CD4+CD44hiCD69hi population (Table 1). By compar-
ing the expression of genes between cell subsets from the WT
and nos2−/− mice, we found that bcl2 expression was reduced
in the absence of nitric oxide for both of the types of cells
(Table 1). However, only within the CD4+CD44hiCD69lo popu-
lation was there an impact of nitric oxide on the expression of il4
and to a lesser degree on il4ra (Table 1). Interestingly, there is
no difference in the expression of the tbx21 (T-bet) or gata3 mas-
ter regulators for IFN-γ and IL-4 within these populations (data
not shown). Taken together, the data support the fact that the
activated effector cells within the mycobacterial granuloma can
be grouped into potentially functional subsets by surface mark-
ers. In particular, the CD4+CD44hiCD69hi population may rep-
resent an IL-2-producing and IL-2- and IFN-γ-responsive, poten-
tially proliferating population whereas the CD4+CD44hiCD69lo
may be unresponsive to IL-2 and IFN-γ. The strong need for
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Figure 3. The number of CD4+ T-bet+ T cells is increased in the organs of Mycobacterium avium infected nos2−/− mice. WT (WT) and nos2−/− mice
were either left uninfected (Uninf) or infected (Inf) intravenously with 106 M. avium 25291 and spleen, lungs, and livers harvested from day 60
through day 120. The organs were processed for flow cytometry and the (A) frequency and (B) number of CD4+T-bet+ cells within the organs
determined. Each symbol represents an individual sample and data are shown as mean ± SEM of n = 4–22, pooled from the five (spleen), four
(lung), or two (liver) experiments performed. *p < 0.05, **p < 0.01, ***p < 0.001, ANOVA.
nitric oxide in induction of IL-4 and reduction of VLA-4 in the
CD4+CD44hiCD69lo population may reflect a novel regulatory
mechanism for the action of nitric oxide on Th1 effector func-
tion.
Nitric oxide inhibition restricts accumulation of
CD69loT-bet+ CD4+ T cells and expression of VLA-4
To confirm that nitric oxide was the active agent limiting the spe-
cific subset of activated CD4+ T cells in M. avium infected mice,
we delivered a specific inhibitor of nitric oxide synthase activity
to infected mice and monitored the development of specific T-cell
subsets. In these experiments, we treated mice early in infection,
as we wanted to be able to detect the CD69loT-bet+ CD4+ T-cell
population in the WT mice. Mice were infected and either left
untreated or treated with aminoguanidine [36] from day 0 to day
30 or day 20 to day 30 and the phenotype of the activated CD4+
T-cell population in the infected organs determined by flow cytom-
etry. We found that both CD69hiT-bet+ and CD69loT-bet+ CD4+
T cells could be detected in the organs of untreated infected mice
(Fig. 6A) and that the frequency of CD69hiT-bet+ CD4+ T cells was
either unaffected (spleen) or modestly reduced by aminoguani-
dine treatment (lung and liver) (Fig. 6A, top panels). In contrast,
the frequency of CD69loT-bethi CD4+ T cells significantly increased
in the organs of all treatedmice (Fig. 6A, lower panels). These data
indicate that the presence of nitric oxide influences the expression
of CD69 in activated CD4+ T cells in all infected organs.
Based on the array data (Fig. 5B), we also wanted to determine
the impact of nitric oxide on the expression of the VLA-4 marker in
CD4+ T cells by measuring the expression of the inducible subunit
CD49d in the infected and aminoguanidine-treated mice. Using
flow cytometry, we found that infection resulted in increased
expression of VLA-4 on T-bet+ CD4+ T cells and that inhibition of
nitric oxide generation resulted in further increased expression of
this marker (Fig. 6B, upper panels). There was also an increased
frequency of VLA-4+Tbet+ cells in the aminoguanidine-treated
mice (Fig. 6B, bottom panels). These data demonstrate that nitric
oxide limits the expression of VLA-4 on the activated CD4+ T cells
in mycobacterially infected mice.
Discussion
In the low dose model of infection, M. avium strain 25291
generates highly necrotic lesions resembling those induced by
M. tuberculosis in humans and the development of necrosis is
entirely dependent upon IFN-γ, IL-12p40, and CD4+ T cells [32,
37]. In high-dose infection models, this strain of M. avium results
in loss of CD4+ T cells [38] and phagocyte-dominated lesions that
do not become necrotic [32].Wewanted to determine whether the
impact of nitric oxide on the granulomatous response to M. avium
25291 was related to the impact of nitric oxide on CD4+ Th1 cells.
The data show that in the absence of Nos2, the inflammatory site
in the liver of M. avium 25291 infected mice is indeed altered.
The WT lesion is characterized by the accumulation of F4/80+,
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Figure 4. A subset of CD4+T-bet+ cells accumulates in the absence of nos2. WT (WT) and nos2−/− mice were either left uninfected (Uninf) or
infected (Inf) intravenously with 106 Mycobacterium avium 25291 and spleen, lungs, and livers harvested from day 60 through day 120. (A) Live
lymphocytes were gated using doublet discrimination, CD3+, and CD4+ expression (Supporting Information Fig. 2A) and then analyzed for T-bet
and CD69 expression. The frequency and number of (B) CD4+T-bet+CD69hi and (C) CD4+T-bet+CD69lo were calculated. Each symbol represents an
individual sample and data are shown as mean ± SEM of n = 4–22, pooled from the five (spleen), four (lung), or two (liver) experiments performed.
*p < 0.05, **p < 0.01, ***p < 0.001; ANOVA.
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Figure 5. CD4+CD44hiT-bet+CD69hi and CD4+CD44hiT-bet+CD69lo cells represent populations with distinct transcriptomes in vivo. WT and
nos2−/− mice were infected intravenously with 106 Mycobacterium avium 25291, spleens were harvested on day 80, and the CD4+CD44hiCD69hi and
CD4+CD44hiCD69lo populations separated by FACS (Supporting Information Fig. 2B). mRNA extracted from the sorted cells underwent microarray
analysis to define differential gene expression between the populations as well as between WT and nos2−/− mice (i.e. four distinct classes). (A)
Differential gene expression between the WT and nos2−/− genotypes and the CD69hi and CD69lo populations (i.e. four classes). Array data were
centered and normalized whereupon gene expression values were filtered to exclude genes with less than 1.5 differential expression (F-test using
a p-value threshold of 0.005). Genes were clustered based on patterns of expression without bias. (Arrows mark gene expression clusters that
differ betweenWT and nos2−/− CD4+CD44hiCD69lo populations.) (B) Biological pathway analysis was performed on the four classes of array data by
screening 3079 filtered unique probes against 218 predefined gene lists (BioCarta Pathways). The “Adhesion Molecule Expression on Lymphocytes”
pathwaywas over-represented in the data set comparedwith that from random chance (p = 0.00031, LS Permutation test). Multiple probes targeted
the same gene resulting in three replicates of Itgb1 and four replicates of Itga4.
p22-phox+ monocytic phagocytes. In contrast, the absence of Nos2
resulted in increased cellular diversity in the granuloma with
F4/80+ p22-phox+ staining phagocytes associating with many
more lymphocytes and neutrophils accumulating in foci within
the lesions. Thus while the WT mice did not control the bacterial
growth as effectively as the nos2−/− mice, the lesions that devel-
oped were less complex and showed no sign of incipient necrosis.
In the absence of Nos2, we show that activated T cells expressing
the Th1-associated T-bet transcription factor and which are low in
expression of CD69 but high in expression of VLA-4, accumulated
to a much higher degree within the lesions. This accumulation of
activated effector T cells was associated with the formation of a
complex granuloma.
The importance of the CD4+ T-cell population during gran-
uloma development and control of mycobacterial infection make
understanding the regulation of this population an important goal.
Previous data has shown that there is an increase in the IFN-γ
response in infected nos2−/− mice [6] and our data complement
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Table 1. Specific gene expression in CD4+CD44hi populations differentially expressing CD69 isolated from the spleens of Mycobacterium avium
infected WT and nos2−/− mice
b)WT nos2−/− WT nos2−/−
Genea) CD69lo CD69lo CD69hi CD69hi
Average p versus p Average p Average p Average
± SDc) nos2d) versus hi ± SD versus hi ± SD versus nos2 ± SD
il2
1449990 at
3.63 ± 0.76 ns 4.20 ± 0.11 6.38 ± 0.59 * 4.94 ± 0.11
** **
il2ra(#)
1420691 at
4.97 ± 0.20 ns 4.86 ± 0.13 6.68 ± 0.05 ns 7.13 ± 0.31
*** ***
il2rb(#)
1417546 at
7.73 ± 0.51 ns 8.38 ± 0.30 8.66 ± 0.13 ** 9.50 ± 0.25
* **
il4
1449864 at
6.58 ± 0.23 *** 4.36 ± 0.34 7.26 ± 0.36 * 5.88 ± 0.65
* *
il4ra
1421034 a at
8.85 ± 0.17 ** 7.91 ± 0.19 8.73 ± 0.19 ns 9.07 ± 0.14
ns **
Ifng
1425947 at
12.3 ± 0.91 ns 13.5 ± 0.15 11.8 ± 0.66 ns 12.5 ± 0.35
ns **
ifngr2
1423557 at
5.48 ± 0.55 * 3.97 ± 0.47 5.52 ± 0.24 *** 3.87 ± 0.20
ns ns
bcl2(#)
1440770 at
9.81 ± 0.36 ** 7.73 ± 0.53 8.10 ± 0.06 ** 6.98 ± 0.22
** nse)
itgb1(#)
1426918 at
8.54 ± 0.27 ** 10.4 ± 0.46 8.70 ± 0.08 nse) 8.29 ± 0.26
ns **
itga4(#)
1421194 at
8.11 ± 0.1 *** 9.33 ± 0.07 8.05 ± 0.07 nse) 8.42 ± 0.05
ns ***
a)Gene represented by specific probes on array. Some genes (marked #) are detected by several probes, in this case, a probe result representative
of all probes for that gene is shown. The probe used is listed under the gene name.
b)RNA from FACS sorted cells of specific CD4+CD44hiCD69 variable phenotype from wild type (WT) and nos2−/− mice infected 80 days previously
with M. avium
c)The log2 expression signal for each of the individual samples within a class (n = 3) was measured and the average ± SD for each class is shown.
d)The values from samples within each group were compared to the values from the other groups and the statistical difference between themeans
was determined by the Student’s t-test (i.e. between genotypes WT versus nos2−/− and phenotypes CD69lo versus CD69hi).
e)For this comparison, only one or two probes showed significance and the majority showed no significance.
this by showing the increased accumulation of T-bet expressing
cells in the absence of nos2−/−. These T-bet expressers are likely
high producers of IFN-γ [39] and their accumulation will con-
tribute to the higher circulating level of IFN-γ in infected nos2−/−
mice. It has been reported that IFN-γ and nitric oxide regulate
the T-cell response in mycobacterial disease [4] but the details
of this control are not fully defined. IFN-γ serves to drive T-cell
apoptosis during mycobacterial infection via direct and indirect
effects [26, 40] and protection against IFN-γ-induced autophagy
is mediated by lrgm1 [41]. We have previously shown that in
vitro generated effector cells, regardless of antigen specificity, are
susceptible to the IFN-γ-mediated detrimental effects of the con-
ditions induced byM. avium strain 25291 [34]. We now show that
there is a specific subset within the pool of activated T cells that
is more susceptible to nitric oxide and that these T cells can be
characterized by a distinct phenotypic and transcriptional profile.
The potential function of the CD4+CD69hi and CD4+CD69lo
populations in the mycobacterial granuloma is addressed by the
data presented here. In particular, the IL-2 data suggest that the
CD4+CD44hiCD69hi cells are more likely to be able to prolifer-
ate and that the CD4+CD44hiCD69lo cells are more akin to the
highly differentiated cells seen in the tuberculosis model [31].
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Figure 6. Nitric oxide inhibition results in increased accumulation of CD4+T-bet+CD69lo cells and increased expression of VLA-4 on T-bet+
CD4+ T cells. WT mice were either left uninfected (UnInf) or infected (Inf) intravenously with 106 M. avium 25291 and either left untreated
(UnTx) or treated (Tx) with the Nos2 inhibitor aminoguanidine throughout the infection (0–30), or for the last 10 (20–30) days of the infection.
(A) Spleens, livers, and lungs were harvested on day 30, the organs processed for flow cytometry and the frequency of T-bet+CD69hi (top) and
T-bet+CD69lo (bottom) in the CD4+ population determined. (B) The expression of T-bet and CD49d were also assessed and the frequency of
T-bet+CD49d+ cells within the CD4+ population in the organs of infected and treated WT mice determined. Data points are for individual mice,
data are shown as mean ± SEM of n = 10, and are pooled from two experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ANOVA.
Similarly, higher expression of the apoptosis-related bcl2 [42] in
the WT populations compared with the nos2−/−-derived popula-
tions suggests that nitric oxide does promote apoptosis in these
effector cells. Most intriguing, however, is the strong difference
seen in the CD4+CD44hiCD69lo population with regard to VLA-4
and IL-4 in the absence of nitric oxide. IL-4 has been shown to
limit VLA-4 expression on activated CD4+ T cells and this reduces
migration of cells into lesional sites [43–45]. Further, upregulation
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of VLA also increases pathogenicity of T cells [46] and improves
SLP-76 interaction with ZAP-70 within the immunological synapse
[47]. Thus, it is possible that in the absence of nitric oxide,
the CD4+CD44hiCD69lo cells produce less IL-4 and it is this that
allows the observed greater VLA-4 expression. The published data
also support the hypothesis that increased VLA-4 will allow for
improved in vivo function and improved ability to accumulate
within the granuloma.
One could propose therefore that the level of nitric oxide
within the lesional site can dramatically impact the local pro-
tective and immunopathological response by reducing accumula-
tion of specific subsets of activated effector cells and by alter-
ing the potency of the lymphocytes with regard to accumula-
tion within the lesion and cytokine production. By demonstrating
the differential impact of nitric oxide on distinct functional sub-
sets of cells, we have identified a mechanism whereby protection
and pathology in mycobacterial disease are modulated by nitric
oxide.
Conclusion
The development of inflammation during mycobacterial infection
is an important component of the disease process and is actively
modulated by CD4+ T cells. Herein, we demonstrate that within
the pool of effector T cells, there is an activated T-cell subset that is
more susceptible to the regulatory factors active within the granu-
loma. Defining the relative protective and pathological role of this
activated T-cell subset (CD4+T-bet+CD69loVLA4hi) will allow for
improved vaccination and immunotherapeutic intervention.
Materials and methods
Mice
All mice were bred at the Trudeau Institute and were treated
according to National Institutes of Health and Trudeau Institute
Animal Care and Use Committee guidelines. All animal protocols
used herein were approved by the Trudeau Institute Animal Care
and Use Committee. C57BL/6 and B6.129P2-nos2tm1Lau (nos2−/−)
(originally purchased from JAX Mice, Maine) were used in these
experiments.
Experimental infection and enumeration of viable
bacteria
Mice were infected with M. avium 25291 (ATTC) at a dose of
1 × 106 cfu by lateral tail vein injection. The level of bacteria
in specific organs was determined by homogenizing the organs
and plating on agar and counting colonies [48,49]. Some infected
WT mice were treated with aminoguanidine hemisulfate (Sigma-
Aldrich) at 2.5 g/100 mL in the drinking water for defined periods
of time; control mice received water without drug.
Histology
Liver sections were placed in 10% neutral-buffered forma-
lin, blocked in paraffin, processed for light microscopy, and
stained with hematoxylin and eosin to provide cell structure.
For immunofluorescence staining, liver sections were harvested
into cold HBSS and 3–4 mm sections cut with a scalpel. Sections
were placed in 4% low-melt agarose (Lonza Seaplaque Agarose,
Fisher Scientific) in HBSS. The solidified gel containing sections
of liver was then sectioned using a vibrating microtome cooled to
4◦C (Leica VT1000) and 200-micron sections were collected into
12-well plates containing HBSS, FcBlock, 5% normal mouse
serum. Sections were stained with fluorescently labeled antibod-
ies, anti-CD4 PE (RM4–5), anti-CD8 PE (clone 53–6.7), Ly6G
PE (clone 1A8) (all from BD Biosciences, CA, USA) and F4/80
Alexa647 (clone Cl:A3–1, AbD Serotec, NC, USA) were added to
the well at a dilution of 1:200 except for F4/80 which was used
at 1:75. Tissues were incubated for 2 h on ice and then washed
twice with excess PBS for 15 min each. Cryosections were gener-
ated from liver tissue harvested in Tissue-Tek which were then air
dried, fixed with neutral-buffered formalin, blocked with 10% nor-
mal mouse serum/1% Triton X-100/1% Tween-20 and exposed
to the following fluorescently labeled antibodies–CD8 allophyco-
cyanin (clone 53–6.7, eBioscience, CA, USA), CD4 PE (as above),
polyclonal rabbit anti-p22-phox (Santa Cruz Biotechnology, CA,
USA), polyclonal Rabbit anti-iNOS (BD Transduction Laborato-
ries, CA, USA) and anti-Rabbit 488 (Invitrogen, NY, USA). Sec-
tions were also exposed to Hoechst DNA stain. All sections were
exposed to appropriate laser light using the Leica SP5 confocal
(Leica Microsystems, Germany) and the light emissions detected
using photomultiplier tubes (PMTs) of the appropriate bandwidth.
Emission spectra were collected using sequential scanning to avoid
spectral bleed-through. The data were collected as Leica image
files using LAS-AF version 2.2.1 software (Leica) and converted
into TIFF using Fiji software (http://fiji.sc/wiki/index.php/Fiji).
Sections were incubated with either CD4/CD8 and F4/80 antibod-
ies or Ly6G and F4/80 antibodies.
Cell preparation and flow cytometry and cell sorting
Lungs of experimental mice were perfused with cold saline con-
taining heparin and placed in cold DMEM (Mediatech-Cellgro).
Livers and spleens were taken directly from experimental mice
and placed in cold DMEM. All organs were then sectioned
using fresh sterile razor blades and placed in DMEM con-
taining collagenase IX (0.7 mg/mL; Sigma-Aldrich) and DNase
(30 μg/mL; Sigma-Aldrich) at 37◦C for 30 min [49,50]. Digested
tissue was gently dispersed by passage through a 70 μm pore
size nylon tissue strainer (Falcon; BD Biosciences); the resultant
single-cell suspension was treated with Gey’s solution to remove
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any residual RBC, washed twice, and counted. The liver cells were
further processed over a 40%:80% Percoll (GE Healthcare) gradi-
ent and then washed and counted. Cell suspensions were stained
for surface markers, washed, processed for intracellular staining
using the eBioscience “Transcription factor staining buffer set”
(eBioscience) according to the manufacturer’s instructions and
then stained for T-bet. The antibodies were titrated for use and
consisted of anti-CD3 (Clone 17A2) labeled with eFluor450, anti-
CD4 (clone RM4–5) labeled with PerCP-Cy5.5, anti-CD69 (clone
H1.2F3) labeled with PE-Cy7, anti-CD44 (clone IM7) labeled with
allophycocyanin-eFluor780, and anti-T-bet (clone 4B10) labeled
with PE (all from eBioscience). Data from stained cells were col-
lected using Diva software on an LSRII flow cytometer (BD Bio-
sciences) and analyzed using FlowJo software (Tristar) and the
gating system is shown in Supporting Information Fig. 2A. Cells
stained as above were also sorted to purity on a BD Influx, 11
color, four laser system based on live lymphocyte, CD4 positive,
CD44 high, and then separated based on the expression of CD69.
An example of the purity of the sorted populations is shown in
Supporting Information Fig. 2B.
Preparation of nucleic acid and microarray analysis
RNA was extracted from purified populations and DNA removed
with the RNeasy Plus Mini Kit (Qiagen, CA, USA) according to the
manufacturer’s instructions. RNA was quality tested and the yield
was between 3.4 and 98 ng/uL per sample. The isolated RNA was
used to generate cRNA which was then biotinylated and prepared
according to the Affymetrix GeneChip 3′ IVT Express Protocol from
150 ng of total RNA. Following fragmentation, 10 μg of cRNA was
hybridized for 16 h at 45◦C on Mouse Genome 430 2.0 arrays.
Arrays were washed and stained in the Affymetrix Fluidics Stations
450. The arrays were scanned using an Affymetrix GeneChip Scan-
ner 3000 7G. Initial QC was performed with Affymetrix Expression
Console using the RMA algorithmwith quantile normalization and
general background correction.
BRB-Arraytools was used for statistical analysis and results
visualization [51] as described [52,53]. Preprocessing with robust
multi-array average with GC-content background correction was
performed on all CEL files to provide background correction using
probe sequence and GC content, quantile normalization, and a
robust multichip model fit using median polish [54] (Support-
ing Information Table 1). GC-content background correction was
selected from various other background correction algorithms
because it yielded the minimum intraclass variation for a sub-
set of experimentally relevant genes [55]. Spot filters, normaliza-
tion, gene filters, and gene subsets: No spot filtering was applied.
Log2 normalization was applied. The median array was used as
a reference array. The default gene filters were applied which
excluded genes having less than 20% of their expression values
and having at least a 1.5-fold change from the median expression
value or if greater than 50% of the expression values are missing.
Only named genes, that is, those without “NA” as their annotated
gene identifier were analyzed, thus excluding nonspecific probes
and array-specific controls. Following these processes, 3366 spe-
cific probes were identified as differentially expressed with 3079
named genes identified. Gene annotation: Genes were annotated
using the Affymetrix HT MG-430B Array (mouse4302) in BRB-
Arraytools. Class comparison: Class comparison was then used to
identify specific genes whose expression correlated with the exper-
imental group (i.e. WT CD69lo, WT CD69hi, nos2−/−CD69lo or
nos2−/−CD69hi) using a univariate F-test at a significance thresh-
old of p = 0.001 that yielded 911 genes.
Gene set class comparison was used to identify biologically rel-
evant pathways by comparing the set of experimentally identified
differentially expressed genes with 218 predefined BioCarta path-
way gene lists (biocarta.com) representing previously investigated
biological pathways. Gene set class comparison identifies biolog-
ical pathways that are over-represented in the experimental data
by comparing the number of differentially expressed genes for
a given BioCarta pathway with that expected by random chance
alone. The significance threshold for this test was p = 0.005 using
a univariate F-test to define differentially expressed genes (as
above) with an LS permutation test used to identify BioCarta gene
sets having more genes differentially expressed among the pheno-
type classes than expected by chance. Of the 218 BioCarta gene
lists tested, 107 gene lists contained one or more differentially
expressed genes, and of these BioCarta gene lists, two were iden-
tified as significantly enriched for differentially expressed genes:
“Adhesion Molecules on Lymphocytes” and “Monocyte and its Sur-
face Molecules,” containing 11 and 12 genes, respectively. When
examined, these two gene sets contained 11 of 12 identical genes.
Hierarchical clustering of genes was used to survey the differ-
entially expressed genes to identify global patterns of expression.
To perform this analysis, the genes were centered and scaled,
using one-minus correlation with average linkage computed.
Statistics
Differences between the means of experimental groups were ana-
lyzed using the two-tailed Student’s t-test or ANOVA as appropri-
ate. Differences were considered significant where p≤ 0.05. Inher-
ently logarithmic data from bacterial growth were transformed for
statistical analysis.
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Supporting Information Figure 1. Live CD4+ T-cell populations in M. avium-infected mice. WT and nos2-/- mice were 4 
either left uninfected (UnInf) or infected (Inf) intravenously with 106 M. avium 25291 and the spleens, lungs and livers 5 
harvested. The organs were processed for flow cytometry and the (A, C) frequency and (B, D) number of live 6 
lymphocytes (LO) (A, B) and CD4+ T cells (C, D) within the organs determined. Cells were gated on live lymphocytes, 7 
doublet discrimination, and CD3+, CD4+ (n=4-22, *P<0.05, **P<0.01, ***P<0.001, by ANOVA). 8 
  9 
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Supporting Information Figure 2. Gating scheme for flow cytometric analysis and cell sorting.  (A) The gating scheme 21 
for the detection of live, single cell, CD3+CD4+CD44+ T cells is shown in sequence. (B) Representative purity of the live, 22 
single cell (i) CD4+CD44+CD69hi  and (ii) CD4+CD44+CD69lo cells sorted prior to RNA extraction. 23 
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